Lucid Diagnostics Inc.

NASDAQ (USD): Lucid Diagnostics Inc. (LUCD)

Last Price

1.01

Today's Change

-0.04 (3.80%)

Day's Change

0.993 - 1.04

Trading Volume

506,491

Overview

Market Cap

59 Million

Shares Outstanding

59 Million

Avg Volume

278,756

Avg Price (50 Days)

0.86

Avg Price (200 Days)

0.92

PE Ratio

-0.83

EPS

-1.21

Earnings Announcement

13-Nov-2024

Previous Close

1.05

Open

1.04

Day's Range

0.9926 - 1.0401

Year Range

0.63 - 1.58

Trading Volume

506,498

Price Change Highlight

1 Day Change

-3.81%

5 Day Change

1.00%

1 Month Change

29.59%

3 Month Change

22.47%

6 Month Change

8.75%

Ytd Change

-27.34%

1 Year Change

-22.31%

3 Year Change

-90.33%

5 Year Change

-91.41%

10 Year Change

-91.41%

Max Change

-91.41%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Devices

Description:

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment